AscellaHealth Partners with Group & Pension Administrators to Present Webinar: TPA-Client Approach to Containing Infusion Therapy Costs

AscellaHealth Partners with Group & Pension Administrators to Present Webinar: TPA-Client Approach to Containing Infusion Therapy Costs




AscellaHealth Partners with Group & Pension Administrators to Present Webinar: TPA-Client Approach to Containing Infusion Therapy Costs

BERWYN, Pa.–(BUSINESS WIRE)–AscellaHealth, a national specialty pharmacy benefit manager (SPBM) serving commercial, Medicare and Medicaid segments, is collaborating with Group & Pension Administrators (GPA), the largest independently owned third-party administrator (TPA) in the Southwest, to present a webinar entitled “A TPA-Client Approach to Specialty Medical Cost Containment Strategy for Infusion Therapy Medications,” April 22, 1:30 p.m. (EDT). Presented by David West, director, Corporate Development, GPA, the event will examine the high cost of infusion therapy, the growing percent of Rx claims for medical plans and how stakeholders can prevent prescription costs from straining employer budgets.

Register in advance for this event here.

“Our comprehensive, innovative medical Rx solution, which includes a partnership with GPA and its integrated PharmWatch, provides a holistic approach to managing drug spend in association with a pharmacy benefit manager as well as for drug claims incurred in the medical plan,” says Dea Belazi, president and CEO, AscellaHealth. “Attendees will gain insights into the benefits of the GPA approach to drug delivery and cost management to offset the impact of specialty drugs, infusion drugs, gene therapies and other high-cost drugs. There will also be valuable guidance on ways to improve average wholesale pricing (AWP), rebates and contract language.”

This is an opportunity to access fresh insights into market trends and solutions and gain a better understanding of the ways that GPA PharmWatch can improve contracts and lowers costs, especially for specialty Rx costs. Specialty drugs are a key concern for benefits payers since they range from hundreds of thousands to millions of dollars per patient. While less than 2% of the patient population requires specialty drugs, they account for approximately 50% or more of total drug spend.

“As a specialty pharmacy benefit manager for GPA, AscellaHealth focuses on drug treatment, especially infusion therapy and injectable drugs provided at an outpatient facility or by a physician in the office,” continues Belazi. “These programs will be featured during the upcoming seminar and subsequent events that we are hosting to serve the industry. Our webinar schedule is robust but targeted, with a goal to engage and inform stakeholders and as an impetus for generating dialogue that delivers added value to established partnerships and clients.”

About AscellaHealth

AscellaHealth, a national specialty pharmacy benefit manager (SPBMTM), serving commercial, Medicare and Medicaid segments, offers high quality prescription drug benefit management services. Complemented by other customizable services, such as carved-out specialty pharmacy services and cost-savings programs, AscellaHealth provides a unique, proprietary service portfolio. Visit www.ascellahealth.com.

Contacts

Media:
Nicole Dufour

CPR Communications

ndufour@cpronline.com
201.641.1911 x 54